Sort
51,593 grants matching “hepatitis”
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
$1,155,157Frederick Lewis Altice · Yale University · R01 · FY2023 · DA
Studies of Pediatric Liver Transplantation
$1,154,346Emmes Corporation · U01 · FY2005 · DK
Durban International Clinical Trials Unit
$1,154,244Umesh G Lalloo · University Of Kwazulu-Natal · UM1 · FY2012 · AI
Pediatric Clinical Research Scholar Program - Washington
$1,154,042Children'S Research Institute · K12 · FY2004 · RR
Silvio O. Conte Digestive Diseases Research Core Centers
$1,153,979Michael H Nathanson · Yale University · P30 · FY2013 · DK
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
$1,153,333Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2017 · DA
Task D06: Woodchuck Animal Model for Testing HBV Therapeutics
$1,153,177Paul Cote · Georgetown University · N01 · FY2014 · AI
Liver-Targeted Prodrugs for the Treatment of Hepatitis C
$1,152,760Metabasis Therapeutics, Inc. · R44 · FY2004 · AI
Stroke with Transfusions Changing to Hydroxyurea
$1,152,696Russell E Ware · St. Jude Children'S Research Hospital · U01 · FY2010 · HL
Cancer Risk in Human Populations
$1,152,632Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Xenobiotic Receptors
$1,152,410Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations
$1,152,360Shuchi Anand · Stanford University · U01 · FY2023 · AI
Development of superior polymerases for next-generation mRNA therapeutic & vaccine manufacturing
$1,152,047Helge Zieler · Primrose Bio, Inc. · R44 · FY2020 · GM
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
$1,151,963Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2023 · AA
The Effects of Oxygen Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$1,151,242Parizad Torabi-Parizi · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Molecular Biology of Hemorrhagic Shock
$1,150,908Timothy R Billiar · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · GM
UCSF Liver Center
$1,150,817Jacquelyn J. Maher · University Of California, San Francisco · P30 · FY2020 · DK
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$1,150,724Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2006 · AI
The Asia-Pacific HIV Observational Database (APHOD)
$1,150,713David A Cooper · Foundation For Aids Research · U01 · FY2007 · AI
DRUG INTERACTIONS
$1,150,566University Of Washington · P01 · FY2000 · GM
Data-Driven Approaches for Opioid Use Disorder Treatment, Recovery, and Overdose Prevention in Rural Communities via Mobile Health Clinics and Peer Support Services
$1,150,429Lior Rennert · Clemson University · R33 · FY2025 · DA
USC Research Center for Liver Disease
$1,150,345Hugo R Rosen · University Of Southern California · P30 · FY2019 · DK
Executing the IND-Enabling Studies for Oral PCSK9/LDLR antagonist
$1,150,186Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2025 · HL
California-Arizona Clinical Trials Network Node
$1,150,000University Of California San Francisco · U10 · FY2005 · DA
Endocannabinoids And Appetitive Functions
$1,149,897George Kunos · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA